Senior insider sale
BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$2.34M
34.16K shares
What this filing means
VALANTINE HANNAH plans to sell 34.16K shares of BRIDGEBIO PHARMA, INC. valued at approximately $2.34M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/10/2026ACC: 0001950047-26-002400
34.16K
Shares to sell
$2.34M
Approx. market value
8.67K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
3/10/2026
8.67KTotal acquired8.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/10/2026 | Stock Option Exercise Cash | 8.67K | — |
| Total | 8.67K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
25.48K
Market value
$1.72M
2/27/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.67K
Market value
$624.3K
3/10/2026
Total
Units
34.16K
Value
$2.34M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/27/2026 | 25.48K | $1.72M | — | Completed |
| Planned — Approximate Date | ||||
3/10/2026 | 8.67K | $624.3K | NASDAQ | Planned |
| Total | 34.16K | $2.34M | ||